$Unitedhealth(UNH.US)

Stephen Hemsley, the CEO of UnitedHealth ($Unitedhealth(UNH.US)), is now watching the stock price fall... People often forget that he was once the CFO and knows the value of strategic buybacks.

Step 1: Blame the quarter, use extremely conservative guidance to set expectations as low as possible...

Step 2: Wait for the stock price to drop, then buy back shares on a large scale...

→ Currently authorized to repurchase 20 million shares (about 7–8 million shares were repurchased in Q2).

The company has $32 billion in cash on hand and can still generate $16 billion in free cash flow annually. With margins recovering, cash flow will continue to grow next year.

Considering antitrust pressure has closed the M&A window, they now have this cash, and the stock price has fallen to pandemic lows—what do you think they will do?

If they repurchase 20 million shares at $250 per share, that's $5 billion. They originally had a $3 billion quarterly buyback program, and it's highly likely they will use up the current authorization and then add another $5 billion buyback.

Additionally, at a dividend of $8.80 per share, repurchasing 20 million shares would save $176 million in annual dividend payments.

With margins recovering, the number of outstanding shares is expected to drop to about 850 million by the end of 2026...

Even at a 4% net margin (historically low), on $475 billion in revenue, that's $19 billion in net profit. Spread over 850 million shares, that's about $22 in earnings per share (EPS).

If the net margin recovers to 4.5% in 2027 and revenue increases to $500 billion, net profit will reach $22.5 billion. Assuming outstanding shares further drop to 815 million (with an additional $12 billion in buybacks), that's about $27 in earnings per share.

In other words, EPS is $16 in 2025 and $27 in 2027.

Every share repurchased now not only saves future cash dividend payments but also disproportionately increases EPS.

Given the company's investment-grade credit rating and low short-term debt—they can easily take on moderate leverage if necessary.

The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.